{
    "title": "Ironwood bulks up on digestive therapies with $1.15 bln VectivBio buy",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12110949/Ironwood-Pharma-acquire-VectivBio-1-15-bln.html",
    "date": "2023-05-22",
    "keywords": [
        "ironwood",
        "drug",
        "vectivbio",
        "mahobe",
        "treatment",
        "deal",
        "bowel",
        "syndrome",
        "therapy",
        "inc",
        "monday",
        "developer",
        "ag",
        "portfolio",
        "share",
        "premium",
        "morning",
        "trade",
        "stock",
        "half",
        "dependence",
        "linzess",
        "abbvie",
        "type",
        "body",
        "latestage",
        "study",
        "yearend",
        "blockbuster",
        "banking",
        "interval",
        "effectiveness",
        "injection",
        "efficacy",
        "ceo",
        "thomas",
        "mccourt",
        "conference",
        "call",
        "commercialization",
        "disease",
        "population",
        "adult",
        "europe",
        "japan",
        "class",
        "glp2s",
        "takeda",
        "reporting",
        "raghav",
        "bengaluru",
        "editing",
        "janane",
        "venkatraman",
        "shounak",
        "dasgupta",
        "sriraj",
        "kalluvila"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}